MARKET

PCRX

PCRX

Pacira Biosciences Inc
NASDAQ
26.00
+0.69
+2.73%
Closed 16:10 01/07 EST
OPEN
25.45
PREV CLOSE
25.31
HIGH
26.48
LOW
25.44
VOLUME
909.17K
TURNOVER
0
52 WEEK HIGH
27.64
52 WEEK LOW
18.17
MARKET CAP
1.12B
P/E (TTM)
55.75
1D
5D
1M
3M
1Y
5Y
1D
Pacira BioSciences to Present at J.P. Morgan Healthcare Conference
Reuters · 21h ago
Weekly Report: what happened at PCRX last week (1229-0102)?
Weekly Report · 3d ago
Pacira BioSciences Stockholder Doma Perpetual Plans to Nominate Three Board Candidates
Dow Jones · 12/30/2025 23:14
DOMA Perpetual Capital to offer nominees for Pacira BioSciences board
Seeking Alpha · 12/30/2025 16:15
DOMA intends to nominate three director candidates at Pacira annual meeting
TipRanks · 12/30/2025 15:45
DOMA Perpetual Capital Pushes for Board Shakeup and Sale at Pacira BioSciences
Reuters · 12/30/2025 15:42
DOMA PERPETUAL CAPITAL MANAGEMENT: ASSERTS PACIRA BIOSCIENCES'S BOARD OF DIRECTORS SHOULD PURSUE AN IMMEDIATE SALE OF COMPANY
Reuters · 12/30/2025 15:41
Press Release: DOMA Perpetual Capital Management Announces Intent to Nominate Three Highly Qualified, Independent Director Candidates at 2026 Annual Meeting of Pacira BioSciences, Inc.
Dow Jones · 12/30/2025 15:41
More
About PCRX
Pacira BioSciences, Inc. is the holding company for its subsidiary, Pacira Pharmaceuticals, Inc. The Company has three commercial-stage non-opioid treatments: EXPAREL (bupivacaine liposome injectable suspension), a long-acting local analgesic approved for infiltration, fascial plane block, and as an interscalene brachial plexus nerve block, an adductor canal nerve block, and a sciatic nerve block in the popliteal fossa for postsurgical pain management; ZILRETTA (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular injection indicated for the management of osteoarthritis knee pain, and iovera, a handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. The Company is also advancing the development of PCRX-201, a locally administered gene therapy with the potential to treat largely prevalent diseases like osteoarthritis.

Webull offers Pacira Biosciences Inc stock information, including NASDAQ: PCRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PCRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PCRX stock methods without spending real money on the virtual paper trading platform.